Blackstone Inc
IDYA icon

Blackstone Inc’s IDEAYA Biosciences IDYA Stock Holding History

Blackstone Inc’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-10,000
Closed -$142K – 186
2020
Q2 		$142K Buy
+10,000
New +$78.8K ﹤0.01% 151

Other funds holding IDYA

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Blackstone Inc's IDYA Position: Q3 2020 in Review

Blackstone Inc sold out of IDEAYA Biosciences (IDYA) in Q3 2020, closing a stake of 10,000 shares — an estimated $142K sold.

Blackstone Inc first reported a position in IDYA in Q2 2020 and held it in 1 quarter. The position peaked at $142K in Q2 2020. 68 funds tracked by Wall St. Rank hold IDYA as of Q3 2020.

  • Blackstone Inc reported no remaining IDEAYA Biosciences position as of Q3 2020 after selling out during the quarter.
  • Blackstone Inc sold 10,000 IDEAYA Biosciences shares in Q3 2020, an estimated $142K.
  • Blackstone Inc first reported a position in IDEAYA Biosciences in Q2 2020 and held it in 1 quarter.
  • Blackstone Inc's IDEAYA Biosciences position peaked at $142K in Q2 2020.
  • 68 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2020.

Based on Blackstone Inc's 13F filing for Q3 2020, filed 16 Nov 2020.